Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#AMLResearch

Home » #AMLResearch
Retrospective Analysis of bZIP Region Mutations in CEBPA Double-Mutated Acute Myeloid Leukemia: Implications for Prognosis and Treatment

Retrospective Analysis of bZIP Region Mutations in CEBPA Double-Mutated Acute Myeloid Leukemia: Implications for Prognosis and Treatment

Posted by By Mourabit Halima 2024.03.17
Editor's note: Acute Myeloid Leukemia (AML) characterized by CCAAT-enhancer binding protein alpha (CEBPA) double mutations (CEBPAdm) represents a distinct subtype with varying clinical outcomes. Recent attention has focused on the…
Read More
Dr. Nigel Russell: The Latest International Treatment Advances in Acute Myeloid Leukemia

Dr. Nigel Russell: The Latest International Treatment Advances in Acute Myeloid Leukemia

Posted by By Mourabit Halima 2024.01.14
Abstract: Dr. Nigel Russell provides insights into the recent developments in the treatment landscape of Acute Myeloid Leukemia (AML). The discussion encompasses the combination of FLT3 mutation inhibitors with intensive…
Read More
Recent Posts
  • 2026 EHA Academic Frontier: Professor Stephen Ansell Deeply Analyzes the Biological Characteristics and Immune Microenvironment Remodeling of Classical Hodgkin Lymphoma
  • EHA 2026 | Interpretation by Professor Todd Knepper: Molecular Surveillance and Clinical Trajectories of Donor-Derived Clonal Hematopoiesis after Allogeneic Hematopoietic Stem Cell Transplantation
  • Frontline Perspectives from EHA 2026: Iterations in CAR-T Manufacturing Processes and Innovations in Engineering Platforms for Multiple Myeloma
  • 2026 EHA Academic Feast: Multiple Myeloma Treatment Enters a New Era of Precision Stratification—From Reshaping ASCT Status to Breaking the Deadlock in Ultra-High Risk Strategies
  • EHA Echoes · Voices from China | Prof. Meng Lü: CAR-T vs Antibody-Based Therapy as a Bridge to Transplantation—Defining the Optimal Stratified Approach for R/R B-ALL
Recent Comments
    Archives
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top